Please login to the form below
Data by
20
Revenue 2014Actavis
The Top Pharma List rankings are compiled from GlobalData's
pharmaceutical revenue figures, which are based on prescription medicine
sales, including generics drugs.
Peter Kelly named managing director of Accord Healthcare UK
Peter Kelly named managing director of Accord Healthcare UK. He was previously commercial director at Actavis UK. ... Choice.”. Meanwhile, former Actavis UK managing director Jonathan Wilson has been appointed vice president, West Europe at Accord
Lilly wins on appeal in Alimta vitamin regimen dispute
Lilly wins on appeal in Alimta vitamin regimen dispute. UK Supreme Court rules in its favour over Actavis. ... The latest ruling "finds the Actavis product infringing, regardless of the diluent used in reconstitution or dilution", said Lilly in a
reactivating drug research programmes
Currently awaiting a possible Supreme Court hearing in the UK, the case of Warner-Lambert v Actavis will determine what conditions have to be met for a medical use claim to ... In fact, in light of Warner-Lambert v Actavis, pharmaceutical companies
MSD probed by UK for blocking Remicade biosimilars
Last year it fined Pfizer £84m for conspiring with Flynn Pharma to raise the price of epilepsy drug phenytoin, and has since launched an investigation into the pricing of Actavis' hydrocortisone
EU starts investigation of Aspen's cancer drug pricing
launched an investigation into the pricing of Actavis' hydrocortisone tablets.
| Global revenue 2014 |
|---|
| 1: Novartis |
| 2: Pfizer |
| 3: Roche |
| 4: Sanofi |
| 5: Merck & Co. |
| 6: Johnson & Johnson |
| 7: GlaxoSmithKline |
| 8: AstraZeneca |
| 9: Gilead Sciences |
| 10: Takeda |
| 11: AbbVie |
| 12: Amgen |
| 13: Teva |
| 14: Lilly |
| 15: Bristol-Myers Squibb |
| 16: Bayer |
| 17: Novo Nordisk |
| 18: Astellas |
| 19: Boehringer Ingelheim |
| 20: Actavis |
| 21: Otsuka |
| 22: Daiichi Sankyo |
| 23: Biogen Idec |
| 24: Baxter |
| 25: Merck KGaA |
| US revenue 2014 |
|---|
| 1: Gilead Sciences |
| 2: Johnson & Johnson |
| 3: Pfizer |
| 4: Roche |
| 5: Novartis |
| 6: Amgen |
| 7: Merck & Co. |
| 8: Sanofi |
| 9: AbbVie |
| 10: Actavis |
| 11: AstraZeneca |
| 12: GlaxoSmithKline |
| 13: Lilly |
| 14: Bristol-Myers Squibb |
| 15: Novo Nordisk |
| CNS revenue 2014 |
|---|
| 1: Pfizer |
| 2: Biogen Idec |
| 3: Novartis |
| 4: Otsuka |
| 5: Teva |
| 6: Johnson & Johnson |
| 7: Lilly |
| 8: Merck KGaA |
| 9: AstraZeneca |
| 10: Shire |
| 11: Bristol-Myers Squibb |
| 12: UCB |
| 13: Lundbeck |
| 14: Eisai |
| 15: GlaxoSmithKline |
| 16: Sanofi |
| 17: Mylan |
| 18: Indivior |
| 19: Actavis |
| 20: Bayer |
Data by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
Featured jobs
-
Programme Director
-
Salary TBC
- Junior - Mid Level Medical Copywriter, Healthcare Advertising Ag...
-
£30-35, 000 according to skills and experience
-
Account Director
-
Salary TBC
- Director of Scientific and Editorial Services
-
Great salary and benefits - Circa 100K
Subscribe to our email news alerts
PMHub
Adelphi Research UK
Adelphi Research UK is a healthcare insight partner. We uniquely blend robust market research with a consultancy approach, to guide...
Latest intelligence
- OUTiCO Case Study - Product Launch
- POSITIVE FORMULARY SUCCESS WITHIN 8 MONTHS!...
- An insight into Multi-Channel Account Management
- At OUTiCO we often talk about moving away from traditional methods, embracing change, and offering an exceptional outsourcing service, but what does that mean day to day?...
- Why AI might be the rep’s best friend
- When looking for the next big thing in digital communication, there’s nothing bigger than the sweeping changes promised by artificial intelligence. There’s little doubt that AI is coming to pharma...
Quick links
Infographics
